BioCryst Pharmaceuticals | BCRX - Capital Social e Reservas





Capital Social e Reservas Alterar Data
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
BioCryst Pharmaceuticals USD -454.29M 99.55M 2026-06
Chugai Pharma JPY 2.03T 135.62B 2025-12
Daiichi Sankyo JPY 1.7T 38.53B 2026-06
DBV Technologies USD 160.4M 47.5M 2026-06
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
Glaxosmithkline GBP 17.42B 4.64B 2026-03
Incyte USD 6.34B 721.58M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Novavax USD -190.71M 45.94M 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06